Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Observational × Quality of Life × Clear all

Status

Sponsor Class

OTHER 5 INDUSTRY 1

Study Type

Observational 1 Interventional 1

Sponsor

Conditions

Breast Neoplasms 391 Neoplasms 272 Carcinoma, Non-Small-Cell Lung 236 Prostatic Neoplasms 179 Colorectal Neoplasms 175 Lung Neoplasms 145 Multiple Myeloma 106 Melanoma 92 Carcinoma, Renal Cell 91 Ovarian Neoplasms 78 Neoplasm Metastasis 59 Carcinoma, Hepatocellular 59 Pancreatic Neoplasms 56 Stomach Neoplasms 55 Urinary Bladder Neoplasms 54 Leukemia, Lymphocytic, Chronic, B-Cell 53 Colonic Neoplasms 45 Leukemia, Myeloid, Acute 44 Uterine Cervical Neoplasms 41 Recurrence 39 Lymphoma, Follicular 38 Liver Neoplasms 38 Lymphoma 34 Hematologic Neoplasms 31 Esophageal Neoplasms 31 Precursor Cell Lymphoblastic Leukemia-Lymphoma 30 Papillomavirus Infections 30 Lymphoma, Large B-Cell, Diffuse 29 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 28 Kidney Neoplasms 28

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01936636 2015-11-05

RELIEF

Galena Biopharma, Inc.

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon ⚡